PMcardio

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

BetterMedicine is an AI software designed for cancer diagnostics and detection. It offers AI-powered solutions to enhance patient outcomes and drive efficiency in radiology workflows. The software is expertly designed by medical professionals and AI specialists, providing trusted and clinically validated solutions. BetterMedicine aims to address inefficiencies in radiology by integrating AI-powered software for detecting lesions on CT scans seamlessly into the workflow, thereby improving efficiency and reducing the risk of oversight. The application focuses on improving patient outcomes, reducing errors, and enhancing the wellbeing of radiology professionals.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Corti is an AI-powered platform that provides real-time decision support, automates documentation and coding, and improves the productivity of patient encounters. It is used by healthcare professionals to enhance the experience of both healthcare professionals and their patients.

Mediscribe Pro is an AI-powered medical scribe and documentation tool designed for healthcare professionals. It utilizes advanced medical language models and artificial intelligence to generate medical dictations, transcriptions, and chart notes. Mediscribe Pro is HIPAA and PIPEDA compliant, ensuring the security and privacy of user data. The tool offers a range of features to streamline medical documentation, including a library of 100+ medical templates, voice-activated note-taking, and seamless integration with existing EMR systems. Mediscribe Pro is designed to reduce administrative burden, improve efficiency, and enhance patient care by allowing clinicians to spend more time with patients and focus on providing quality care.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

NovaResp cMAP™ is an AI-powered platform software designed to improve adherence to Continuous Positive Airway Pressure (CPAP) therapy for sleep apnea patients. It utilizes artificial intelligence and machine learning to predict and prevent apnea episodes during therapy, delivering personalized treatment at more comfortable air pressure levels. The application aims to enhance patient quality of life, increase sales for device manufacturers, and reduce labor costs for DMEs. NovaResp cMAP™ is compatible with all major PAP machines and is a revolutionary solution in the treatment of Obstructive Sleep Apnea (OSA).

PolygrAI is a digital polygraph powered by AI technology that provides real-time risk assessment and sentiment analysis. The platform meticulously analyzes facial micro-expressions, body language, vocal attributes, and linguistic cues to detect behavioral fluctuations and signs of deception. By combining well-established psychology practices with advanced AI and computer vision detection, PolygrAI offers users actionable insights for decision-making processes across various applications.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Neuralink is a pioneering brain-computer interface (BCI) application that aims to redefine human capabilities by creating a generalized brain interface to restore autonomy to individuals with unmet medical needs. The application focuses on developing fully implantable BCIs that allow users, particularly those with quadriplegia, to control computers and mobile devices using their thoughts. Neuralink's innovative technology includes advanced chips, biocompatible enclosures, and surgical robots for precise implantation. The application prioritizes safety, accessibility, and reliability in its engineering process, with future goals of restoring vision, motor function, and speech capabilities.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

Medical Brain is an AI-powered clinical assistant designed for both patients and providers. It engages with users to identify health risks and care gaps early, providing actionable insights and guidance to improve outcomes and intercept high-cost ER visits. The platform monitors patients 24/7, aggregates and understands all patient data, and generates real-time actions based on AI clinical decision support and automation. Medical Brain incorporates evidence-based best practices in various clinical modules and continuously learns from user experiences to enhance efficiency and intelligence.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

InformAI is a technology company dedicated to advancing healthcare through the development of AI-driven solutions. We focus on crafting high-quality, AI-driven enterprise software solutions that address specific clinical needs. We target critical medical fields including radiology, radiation oncology, and high acuity informatics. Our portfolio, featuring our flagship RadOncAI and our development pipeline products of SinusAI and TransplantAI, is designed to deliver impactful solutions that enhance healthcare quality, safety and efficiency.

Covera Health is a clinical intelligence platform that supports the end-to-end delivery of clinical-grade, AI-powered quality insights for providers and insurers. The platform is seamlessly integrated across the healthcare ecosystem to elevate everything from diagnosis and care coordination to prior authorization and claims administration. Covera Health is certified by AHRQ as a Patient Safety Organization to safeguard access to provider and patient data.

Medcol.io is a clinical AI assistant designed to support healthcare professionals in making informed decisions by providing evidence-based recommendations and insights. The platform leverages advanced algorithms and medical data analysis to assist in diagnosing diseases, suggesting treatment plans, and predicting patient outcomes. With a user-friendly interface and real-time updates, Medcol.io aims to streamline the clinical decision-making process and improve patient care.

Glass Health is an AI-powered clinical decision support platform that empowers clinicians by providing tools to develop differential diagnoses and draft clinical plans. The platform combines cutting-edge AI technology with evidence-based medical knowledge to streamline diagnostic decisions and optimize clinician workflows. Glass Health's mission is to leverage technology to enhance the practice of medicine, increase diagnostic accuracy, implement evidence-based medicine, promote health equity, and improve patient outcomes globally. The platform is built by clinicians, for clinicians, with a deep commitment to safety, ethics, and alignment.

MediNav is an AI-powered medical assistant that learns and reduces documentation time for healthcare professionals. It is not just a medical dictation software but an assistant based on a complex algorithm that retains, notes, extracts medical information, and continuously learns. By using advanced speech recognition technology combined with natural language processing, MediNav offers efficient and intuitive assistance to healthcare providers, resulting in reduced costs, more time for patient care, and faster delivery of imaging results. It is primarily used in Romanian and is expanding to include other European languages like German, Spanish, and Polish.

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.

Caption Care provides accessible cardiac ultrasounds to detect heart disease earlier, when it's easier and more cost-effective to manage. The result: better patient outcomes, more accurate risk scoring, and reduced downstream costs.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Eko is a digital stethoscope company that offers AI disease detection and telehealth solutions. Their products include digital stethoscopes with AI capabilities, mobile apps for visualization, and enterprise solutions for health systems. Eko aims to provide clinicians with advanced tools for cardiac and pulmonary disease detection, improving patient care and outcomes. The company also offers educational resources, customer stories, and news updates related to healthcare technology.

Dorascribe is an AI medical scribe application designed to assist doctors in real-time note-taking during medical consultations. It offers a simple-to-use medical transcription app that converts live conversations into detailed patient notes, helping healthcare professionals optimize their medical documentation process. With features like instant recording, detailed documentation, and time-saving capabilities, Dorascribe streamlines workflow, enhances patient interactions, and ensures data accuracy. The application prioritizes security and privacy, adhering to HIPAA regulations and offering support across multiple devices. Users can save significant time on charting and benefit from personalized templates and workflows. Dorascribe has received positive feedback from various healthcare professionals for its efficiency and accuracy in medical note-taking.

Unlearn.ai is an AI-driven platform that specializes in streamlining clinical trials through the use of AI-generated digital twins of patients. By leveraging digital twin technology and disease-specific ML models, Unlearn.ai enables researchers to design and run more efficient and impactful clinical trials across various therapeutic areas. The platform offers solutions to accelerate trial timelines, facilitate faster decision-making, and optimize trial design, ultimately enhancing trial efficiency, insights, and impact.

Eight Sleep is an intelligent bed cooling system that offers exceptional sleep experiences by actively adjusting temperature, elevating the body, and playing integrated soundscapes to improve sleep quality. The Pod works with any mattress to enhance sleep based on individual sleep stages, biometrics, and environment. It provides fully immersive cooling and heating comfort, elevation through an intelligent adjustable base, and integrated surround sound for a personalized sleep environment. The application is clinically proven to deliver real results, including faster sleep onset, more deep sleep, reduced snoring, and fewer night wake-ups. Backed by industry leaders and over 50 clinical studies, Eight Sleep is committed to optimizing rest for peak health and performance.

Woebot Health is a chat-based AI wellness tool that aims to make mental health support radically accessible. Founded in 2017 by clinical research psychologist Dr. Alison Darcy, Woebot Health focuses on providing empathetic and rigorous mental health care through supportive relationships. The tool offers personalized services to improve mental health outcomes and is designed to adapt to the changing needs of individuals and organizations.

Suki AI is an AI-powered healthcare assistant that offers ambient documentation, clinical reasoning, assisted coding, and compliance solutions for clinicians. It provides a robust SDK and suite of APIs for integrating AI capabilities into healthcare applications. Suki aims to reduce the burden of documentation, allowing clinicians to focus on patient care. The platform is fully integrated with major enterprise EHR systems and ensures safe, clinician-reviewed documentation. Suki has a high adoption rate and delivers proven ROI by increasing coding accuracy and clinician efficiency.

Glass Health is an AI-powered clinical decision support platform that empowers clinicians by providing tools to develop differential diagnoses and draft clinical plans. The platform combines cutting-edge AI technology with evidence-based medical knowledge to streamline diagnostic decisions and optimize clinician workflows. Glass Health's mission is to leverage technology to enhance the practice of medicine, increase diagnostic accuracy, implement evidence-based medicine, promote health equity, and improve patient outcomes globally. The platform is built by clinicians, for clinicians, with a deep commitment to safety, ethics, and alignment.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Sully.ai is the #1 all-in-one AI solution designed to save doctors' time by creating superhuman doctors. The platform offers a comprehensive set of features such as pre-visit screening, decision support, scribing, diagnosis assistance, clinical planning, and post-visit automations. Sully.ai is an automation platform that works seamlessly with Electronic Medical Records (EMR) systems, providing personalized and multilingual support for healthcare professionals. The AI model is HIPAA compliant and trained on real-life doctor encounters to enhance decision-making and streamline administrative tasks. With proven results in reducing repetitive tasks and improving efficiency, Sully.ai aims to transform healthcare delivery by empowering doctors to focus on patient care.

Neural Consult is a cutting-edge AI-powered medical education platform that offers personalized learning tools to empower medical students. The platform provides unlimited board questions, Anki cards, clinical simulations, and more, tailored to individual study needs. With features like question generation, lecture summaries, differential diagnosis, and AI-powered case simulations, Neural Consult revolutionizes the way medical students learn and prepare for exams. Trusted by students at top medical schools, Neural Consult aims to enhance clinical reasoning, memorization skills, and overall learning efficiency through innovative AI technology.

Neuralink is a pioneering brain-computer interface (BCI) application that aims to redefine human capabilities by creating a generalized brain interface to restore autonomy to individuals with unmet medical needs. The application focuses on developing fully implantable BCIs that allow users, particularly those with quadriplegia, to control computers and mobile devices using their thoughts. Neuralink's innovative technology includes advanced chips, biocompatible enclosures, and surgical robots for precise implantation. The application prioritizes safety, accessibility, and reliability in its engineering process, with future goals of restoring vision, motor function, and speech capabilities.

Medical Brain is an AI-powered clinical assistant designed for both patients and providers. It engages with users to identify health risks and care gaps early, providing actionable insights and guidance to improve outcomes and intercept high-cost ER visits. The platform monitors patients 24/7, aggregates and understands all patient data, and generates real-time actions based on AI clinical decision support and automation. Medical Brain incorporates evidence-based best practices in various clinical modules and continuously learns from user experiences to enhance efficiency and intelligence.

Health Imaging is an AI-powered platform that focuses on providing cutting-edge solutions in medical imaging and healthcare management. The platform offers a wide range of features and tools that leverage artificial intelligence to enhance diagnostic accuracy, streamline workflows, and improve patient care. From advanced imaging technologies to AI-based training solutions, Health Imaging is at the forefront of innovation in the healthcare industry.

Simbo AI is a Gen AI platform designed for healthcare enterprises, offering autonomous applications for medical practice automation. It combines LLM and symbolic knowledge bases to provide hallucination-free responses. The platform is fully controllable, consistent, secure, and responsible, ensuring accurate and reliable AI interactions. Simbo AI utilizes Symbolic RAG technology with Lossless NLU for exact search and fact-checking capabilities. It aims to automate medical practices, reduce costs, and improve patient care, ultimately enhancing the lives of doctors and patients.